Within hours of securing a gastrointestinal drug from Korea's Hanmi, Lilly has ramped up the biobuck...
Lilly locks in vague, 5-program pact with Haisco worth up to $3B
Within hours of securing a gastrointestinal drug from Korea's Hanmi, Lilly has ramped up the biobucks for a wider-ranging pact with China's Haisco.
Author: Fierce Biotech
Read Original Article